Ratings by H.C. Wainwright (Sara Nik)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/16/2026 | Eikon Therapeutics Inc. | EIKN | New Coverage | Buy (N/A) |
7.54 (8.24) |
9.28% | Details | |
| 8/17/2026 | Tvardi Therapeutics Inc | TVRD | Maintain | Buy (Buy) |
|
Details | ||
| 6/8/2026 | Tvardi Therapeutics Inc | TVRD | New Coverage | Buy (N/A) |
2.89 (0.97) |
-66.44% | Details | |
| 12/8/2025 | Pasithea Therapeutics Corp. | KTTA | New Coverage | Buy (N/A) |
1.13 (0.45) |
-60.18% | Details | |
| 9/10/2025 | Moleculin Biotech | MBRX | Maintain | Buy (Buy) |
|
Details | ||
| 6/9/2025 | Moleculin Biotech | MBRX | New Coverage | Buy (N/A) |
0.67 (5.89) |
779.1% | Details | |
| 5/19/2025 | Curis | CRIS | New Coverage | Buy (N/A) |
2.03 (0.40) |
-80.3% | Details |
